THERAPEUTICS INC has a total of 40 patent applications. Its first patent ever was published in 1999. It filed its patents most often in South Africa, WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets pharmaceuticals, packaging and shipping and organic fine chemistry are BIAL - PORTELA & CA S A, BONNIE DAVIS and SCHERING PLOUGH KABUSHIKI KAIS.
# | Country | Total Patents | |
---|---|---|---|
#1 | South Africa | 19 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Brazil | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Mexico | 2 | |
#9 | Philippines | 2 | |
#10 | Singapore | 2 | |
#11 | EAPO (Eurasian Patent Organization) | 1 | |
#12 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Packaging and shipping | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Packaging | |
#4 | Containers for goods storage | |
#5 | Sugars | |
#6 | Heterocyclic compounds | |
#7 | Peptides | |
#8 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Hammer James D | 15 |
#2 | Gauthier Robert T | 15 |
#3 | Palle Venkata P | 8 |
#4 | Alden Iv Wayne S | 6 |
#5 | Elzein Elfatih O | 5 |
#6 | Elzein Elfatih | 5 |
#7 | Ibrahim Prabha N | 5 |
#8 | Zablocki Jeff A | 5 |
#9 | Zablocki Jeffrey A | 5 |
#10 | Robert T Gauthier | 4 |
Publication | Filing date | Title |
---|---|---|
WO2017103720A1 | Corticosteroid containing foam compositions and method of manufacture thereof | |
CA3008753A1 | Halobetasol foam composition and method of use thereof | |
WO2006029013A2 | Topical dermatological formulations and use thereof | |
ZA200403485B | A2B adenosine receptor antagonists. | |
ZA200303967B | ABCA-1 elevating compounds. | |
ZA200301684B | Purine ribosides as antiarrhythmics. | |
ZA200110169B | Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter protein ABC1. |